Evaluation of Procalcitonin Serum Levels in Children Younger than Five Years Old with Urinary Tract Infection

Main Article Content

Mohsen Akhavan Sepahi
Mohammad Kazem Moslemi
Mohammad Reza Haeri

Abstract

Background: Children with vesicoureteral reflux (VUR) are posed to the danger of recurrent pyelonephritis, kidney scar and renal failure. Nowadays, the evaluation of VUR is carried out using different imaging methods that are accompanied with different limitations. Pediatricians usually look for other evaluation methods that are feasible, easy to implement and carries the least amount of danger to the patient. 

Objectives: The aim of this study was to investigate the level of serum Procalcitonin (PCT) as a predictor of VUR instead of the voiding cystourethrogram (VCUG).

Methods: This case-control study was conducted from 2013 to 2014. One hundred and ten children younger than five years old were divided into two groups: (i) the case group with 76 children diagnosed with urinary tract infection (UTI) using urine culture test, and (ii) the control group with 34 healthy children. Serum levels of PCT were measured by a commercial kit. Demographic data were collected using a questionnaire and analyzed by software SPSS.

Results: Of the samples, 69.1% of them had no VUR, 20% and 10.9% of the samples suffered from severe unilateral VUR and severe bilateral VUR, respectively. With regard to the level of serum PCT, 61.8% of the samples were positive. One-half of those samples (38 people) who was diagnosed to be healthy had a normal level of serum PCT. However, 30 people (88.2%) of the samples diagnosed to be healthy using VCUG had increased level of serum PCT. The positive and negative predictive values of the level of serum PCT were 44% and 90%, respectively. In this respect, 50% of the samples diagnosed by using level of serum PCT were false positive and 11.8% were false negative. The kappa score for the level of serum PCT was 0.3 (P < 0.0001). The positive predictive value of the serum level of PCT for the female and male samples were 43% and 50% respectively.

Conclusions: There was no statistically significant relationship between VUR and the serum level of PCT.

Keywords:
Children, urinary tract infection, procalcitonin (PCT), vesicoureteral reflux (VUR).

Article Details

How to Cite
Sepahi, M. A., Moslemi, M. K., & Haeri, M. R. (2020). Evaluation of Procalcitonin Serum Levels in Children Younger than Five Years Old with Urinary Tract Infection. Asian Journal of Pediatric Research, 4(4), 31-37. https://doi.org/10.9734/ajpr/2020/v4i430158
Section
Original Research Article

References

Elder JS, Vesicoureteral Reflux. In: Elder J, Behrman RE, Kliegman RM, Jenson HB. Nelson textbook of Pediatrics. 17th Ed. Philadelphia: W.B Saunders company. 2016;2562-4.

Akhavan Sepahi M, Sharifiain M, Sadr Moharrerpour S. Pediatric Vesicoureteral Reflux Approach and Management. Caspian J Pediatr March. 2017;3(1):209-14.

Sharifian M, Mohkam S, Akhavan Sepahi M. Spontaneous resolution of vesicoureteral reflux (VUR) in Iranian children: a single center experience in 533 cases. Nephro-Urol Mon. 2011;3:191-5.

Fukui S, Watanabe M, Yoshino K. Intrarenal reflux in primary vesicoureteral reflux. International Journal of Urology. 2013;20(6):631-6.

Akhavan Sepahi M, Eftekhari SS, Rashidinia Sh, et al. The Relationship between Urinary Reflux and Nephrolithiasis in Children: A Cross-Sectional Study. Int J Pediatr. 2017;5(5):4965-73. DOI: 10.22038/ijp.2017.22728.1898

Akhavan sepahi M, Eftekhari SS, Shahmoradi S, Talebizadeh M, Rashidinia Sh, Hejazi SS. Metabolic and Anatomic Abnormalities Associated with Pediatric Nephrolithiasis: a Cross-Sectional Study. Int J Pediatr. 2017;5(5):4833-38. DOI: 10.22038/ijp.2017.22705.1896

Tej K. Mattoo, Ranjiv Mathews, and Indra R. Gupta, Vesicoureteral Reflux and Renal Scarring in Children in: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Golstein S. Pediatric nephrology. 7th Ed. Baltimore: Williamsi Wilkins. 2016;P1715-1748.

Sorkhi H, Hashemi M. Renal scan in children with vesicoureteral reflux and urinary tract infection. Journal of Mazandaran University of Medical Scinces. 2005;15(47):78-83.

Carrol ED1, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. International Journal of Antimicrobial Agents. 2002;20(1):1-9.

Muddassir Muhammad Shaikh MM, Hermans LE, Jacob M. van Laar. Is serum procalcitonin measurement a useful addition to a rheumatologist’s repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections. Rheumatology. 2015;54(2):231-240.

Song JU, Lim SY, Kwag HJ, Lim SY, et al. The Clinical Utility of Serum procalcitonin In Immonocompetents Patients with Pleural Tuberculosis. Acta Medica Mediterranea. 2016;32:447.

Hassan Ghobadi, Shahrzad M. Lari, Firouz Amani, Shahram Habibzadeh,Amirhosein Karimi , Farhad Pourfarzi. The Impact of Treatment on Serum Level of Procalcitonin in Patients with Active Pulmonary Tuberculosis. Journal of Cardiothoracic Medicine. 2014;2(4):238-242.

Janota J, Simák J, Stranák Z. Procalcitonin--a marker of systemic infection and multiorgan dysfunction: characteristics of the gene and protein. Cesk Fysiol. 2001;50(3):119-24.

Leroy S, Adamsbaum C, Marc E, et al. Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection. Pediatrics. 2005;115:706-709.

Sandrine Leroy, Alain Gervaix . Procalcitonin: A Key Marker in Children with Urinary Tract Infection .Advances in Urology; 2011. Article ID 397618, 7 page227.

Sun HL1, Wu KH, Chen SM, Chao YH, Ku MS, Hung TW, Liao PF, Lue KH, Sheu JN. Role of procalcitonin in predicting dilating vesicoureteral reflux in young children hospitalized with a first febrile urinary tract infection Pediatr Infect Dis J. 2013;32(9):e348-54.

Leroy S, Bouissou F, Fernandez-Lopez A, Gurgoze MK, Karavanaki K et al. Prediction of High-Grade Vesicoureteral Reflux after Pediatric Urinary Tract Infection: External Validation Study of Procalcitonin-Based Decision Rule. PLoS ONE. 2011;6(12):e29556. DOI:10.1371/journal.pone.0029556

Rahimzadeh N, Otukesh H, Hoseini R, Shadani S, Hooman N. Serum procalcitonin level for prediction of high-grade vesicoureteral reflux in urinary tract infection. Iran J Kidney Dis. 2014;8(2):105-8.

Gendrel D1, Leroy S, Bréart G, Chalumeau M. Procalcitonin and prediction of vesico-ureteral reflux in pediatric urinary tract infection. Bull Acad Natl Med. 2007;191(8):1731-43.

Ji-Nan Sheu, Hung-Ming Chang, Shan-Ming Chen. The Role of Procalcitonin for acute pyelonephritis and subsequent renal scarring in infants and young children, Pediatric Urology. 2011;2002-2007.

Mohkam M, Farshid Kompani , Alireza Ghafari .Diagnostic Values of Serum Procalcitonin in Kidney Diseases. Journal of pediatrics nephrology. 2015;3(1):7-12.

Leroy S, Romanello C, Galetto-Lacour A, et al. Procalcitonin is a predictor for high-grade vesicoureteral reflux in children: Meta-analysis of individual patient data, The journal of Pediatrics. 2011;159(4):644-651.